Skip to main content
SpringerLink
Log in

Comment on Rosenbaum-Krumme et al.: 18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Rosenbaum-Krumme SJ, Görges R, Bockisch A, Binse I. (18)F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy. Eur J Nucl Med Mol Imaging 2012. doi:10.1007/s00259-012-2065-4.

  2. Feine U, Lietzenmayer R, Hanke JP, Held J, Wöhrle H, Müller-Schauenburg W. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 1996;37:1468–72.

    PubMed  CAS  Google Scholar 

  3. Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY. Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med 2012;37:121–7.

    Article  PubMed  Google Scholar 

  4. Soelberg KK, Bonnema SJ, Brix T, Hegedus L. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography. A systematic review. Thyroid 2012. doi:10.1089/thy.2012-0005.

  5. Morani F, Pagano L, Prodam F, Aimaretti G, Isidoro C. Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression. Panminerva Med 2012;54:59–63.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University of Brescia and Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy

    Francesco Bertagna & Raffaele Giubbini

Authors
  1. Francesco Bertagna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raffaele Giubbini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Bertagna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertagna, F., Giubbini, R. Comment on Rosenbaum-Krumme et al.: 18F-FDG PET/CT changes therapy management in high-risk DTC after first radioiodine therapy. Eur J Nucl Med Mol Imaging 39, 1658–1659 (2012). https://doi.org/10.1007/s00259-012-2191-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-012-2191-z

Keywords

Search

Navigation